Targeting Rare Diseases and Critical Care.

For almost 30 years, AOP Health has been dedicated to the pharmaceutical and clinical development and commercialization of medicines. 

Our motivation at AOP Health is to help patients suffering from rare diseases. We achieve this by working together with stakeholders in the German healthcare system. Cooperation in the pharmaceutical and healthcare industry is crucial in order to develop solutions for patients and make them available - especially in the treatment of rare and complex diseases.

AOP Health is represented in many countries, but Germany has a special position, as the country was one of the company's first expansions. AOP Health Germany began its development in 2011 and was transformed into a legal entity in 2018. 

AOP Health Germany currently employs a team of 60 people. At the Ismaning site, 18 employees work in the areas of Marketing & Sales, Medical, Market Access, Accounting, Controlling, HR and Office Management.

Whether a disease is defined as a rare disease depends on the frequency of its occurrence in the population. However, from the global point of view the definition is not consistent. Thus, in Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases.